Protalix BioTherapeutics (PLX) Capital Expenditures Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 16.27% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 4.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.87% |
| Dec 31, 2025 | -140.83% |
| Sep 30, 2025 | 58.95% |
| Jun 30, 2025 | 59.98% |
| Mar 31, 2025 | 23.08% |
| Dec 31, 2024 | -49.57% |
| Sep 30, 2024 | 28.86% |
| Jun 30, 2024 | -54.63% |
| Mar 31, 2024 | 15.71% |
| Dec 31, 2023 | 97.73% |
| Sep 30, 2023 | -58.09% |
| Jun 30, 2023 | -1.27% |
| Mar 31, 2023 | 55.47% |
| Dec 31, 2022 | 50.17% |
| Sep 30, 2022 | -31.86% |
| Jun 30, 2022 | -81.71% |
| Mar 31, 2022 | 10.44% |
| Dec 31, 2021 | 53.84% |
| Sep 30, 2021 | 49.00% |
| Jun 30, 2021 | 24.68% |
| Mar 31, 2021 | 15.73% |
| Dec 31, 2020 | -30.40% |
| Sep 30, 2020 | -9.59% |
| Jun 30, 2020 | -13.10% |
| Mar 31, 2020 | -33.06% |
| Dec 31, 2019 | -84.52% |
| Sep 30, 2019 | 35.66% |
| Jun 30, 2019 | -51.48% |
| Mar 31, 2019 | -12.18% |
| Dec 31, 2018 | -312.62% |
| Sep 30, 2018 | -6.69% |
| Jun 30, 2018 | -14.62% |
| Mar 31, 2018 | 35.99% |
| Mar 31, 2017 | -5.78% |
| Dec 31, 2016 | -19.22% |
| Sep 30, 2016 | -21.70% |
| Jun 30, 2016 | -22.61% |
| Mar 31, 2016 | -26.88% |
| Dec 31, 2015 | -74.84% |
| Sep 30, 2015 | -45.02% |
| Jun 30, 2015 | -0.57% |
| Mar 31, 2015 | -50.37% |
| Mar 31, 2014 | -53.43% |
| Dec 31, 2013 | -40.22% |
| Sep 30, 2013 | -37.56% |